Reject ‘Big 3’ health fund increases over 3%, evidence shows

18 November, 2019

The ‘Big 3’ corporate health funds have no reason to raise their prices more than 3 per cent next year, new evidence shows, with the Federal regulator APRA urged to reject any that do.

Therapeutic Development a key focus of the Roadmap

15 May, 2017

The Medical Technology Association of Australia (MTAA) welcomes the 2016 National Research Infrastructure Roadmap and its recommendations, in particular around the need to increase capacity to develop new therapies or medical devices.

File
Public

Procurement survey results

  • 25 Sep 2019
  • Sponsorship

Important Notice on Prostheses List Applications

26 April, 2023

Significant changes to the upcoming 14 May application deadline for the 1 November Prostheses List. Recommend taking action early.

Group
Public

Australian MedTech Innovation: The Clinical Research Landscape PDF Presentations

  • 26 May 2017
  • PD Training Catalogues

Prostheses Reform update

25 September, 2019

Prostheses Reform update

MedTech Networking - 10 August, 2023

10 August MTAA Members-Only Networking Event

Sydney, NSW

An exclusive MTAA Members-Only Networking Event. MTAA invites our valued members to join us for drinks and canapes as we thank you for your ongoing support. 

Medical Technology sector welcomes MTPConnect Clinical Trials report

22 June, 2017

The Medical Technology Association of Australia (MTAA) welcomes the MTPConnect Clinical Trials report published today.

The report highlights the significant contribution clinical trials makes to the Australian economy, shows we have a competitive advantage on a global level and details how we can grow into the future.

Prostheses List Abbreviated Pathway Pilot Opportunity

08 November, 2019

Members may be aware that MTAA is working with the Department of Health to implement a new Abbreviated Pathway for certain types of Prostheses List applications. The Department has advised that it will run a pilot for the proposed Abbreviated Pathway for the next round of PL applications starting in January. The pilot will run in parallel with the standard pathway – in other words, a sponsor’s application would be considered under both pathways simultaneously. However, only the decision arising from the standard pathway will stand.

Prescribed List (formerly Prostheses List) Reform Update

10 August, 2023

Changes to the Prescribed List (PL) continue to be implemented and consultations are also underway. There has been recent media relating to the government announcement back on 14 June to postpone delisting of General Use items (Part D) from the PL but without having any interim bundling arrangements. The news reflected commentary by stakeholders not any new government policy. MTAA continues to work to push back on this policy, particularly the unanticipated additional 10% reduction.